Evidence map›Paper›PMID 42504959›Full record

ArticleAngewandte Chemie (International ed. in English)2026

One Molecular Platform, Three Distinct Narrowband Organoboron TADF Emitters: A Divergent One-Pot Strategy From Green to Red.

Jun Hyeon Lee, Minlang Yang, Takuma Yasuda

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jun Hyeon LeeDepartment of Applied Chemistry, Graduate School of Engineering, Kyushu University, Fukuoka, Japan.
Minlang YangDepartment of Applied Chemistry, Graduate School of Engineering, Kyushu University, Fukuoka, Japan.
Takuma YasudaDepartment of Applied Chemistry, Graduate School of Engineering, Kyushu University, Fukuoka, Japan.ORCID https://orcid.org/0000-0003-1586-4701

Funding

Hoso Bunka FoundationIketani Science and Technology FoundationJSPS KAKENHI JP24K21248JSPS KAKENHI JP25K01848JSPS KAKENHI JP26KJ1808JSPS Research FellowshipJST CREST JPMJCR21O5Kuma Foundation
6 · The paper itself

Abstract

Multi-resonance thermally activated delayed fluorescence (MR-TADF) emitters enable narrowband electroluminescence with exceptional color purity in organic light-emitting diodes (OLEDs). However, extending emission to longer wavelengths, particularly into the red region, while preserving spectral sharpness remains challenging. Here, we report a divergent one-pot borylation strategy that transforms a single 5,11-dihydroindolo[3,2-b]carbazole platform into three structurally distinct organoboron MR-TADF emitters spanning green to red. This approach harnesses competing mono- and double-borylation pathways that coexist under the reaction conditions to generate multiple emitters in a single operation. The resulting MR-TADF emitters (BN-G, BN-Y, and BN-R) exhibit ultranarrow green, yellow, and red photoluminescence with full widths at half maximum below 25 nm and near-unity quantum yields (96%-100%) in doped films. OLEDs based on these emitters achieve maximum external quantum efficiencies of up to 35.3%, with emission maxima spanning 516-601 nm. This study establishes a unified design strategy for generating multiple high-performance MR-TADF emitters from a single precursor, providing a versatile platform for the development of color-tunable narrowband optoelectronic materials.

Indexed as

indolocarbazolenarrowband emissionorganic light‐emitting diodethermally activated delayed fluorescencevibronic coupling

Identifiers

PMID42504959
PMCPMC13592323

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.